You are here: Industry Insights > QuintilesIMS

News List

Exponential Pharma Growth Expected in China by 2022 biospace
April 23, 2018
It’s no secret that China has become an ever-increasing important component for drug development.
QuintilesIMS is now IQVIA expressbpd
November 07, 2017
QuintilesIMS announced that it will be changing its name to IQVIA, a company dedicated to using analytics and science to help healthcare stakeholders find better solutions for their patients, effective November 6, 2017.
US Drug Spending Growth of 4.8 Percent in 2016 According to QuintilesIMS Institute Study americanpharmaceuticalreview
May 09, 2017
Growth in U.S. spending on prescription medicines fell in 2016 as competition intensified among manufacturers, and payers ramped up efforts to limit price increases, according to research released today by the QuintilesIMS Institute.
QuintilesIMS Reports First-Quarter 2017 Results and Raises Full-Year 2017 Adjusted Diluted EPS Guida quintilesims
May 04, 2017
Quintiles IMS Holdings, Inc. reported financial results for the quarter ended March 31, 2017.
QuintilesIMS in alliance with Salesforce financialexpress
April 27, 2017
To build next generation solutions for life sciences firms
QuintilesIMS to Announce First-Quarter 2017 Results on May 3, 2017 IMS Health
April 25, 2017
Quintiles IMS Holdings, Inc. (“QuintilesIMS”) (NYSE: Q) will announce its first-quarter 2017 financial results before the market opens on Wednesday, May 3, 2017. The QuintilesIMS management team will host a conference call and webcast at 9:00 a.m. Eastern
QuintilesIMS Announces Pricing of Senior Notes IMS Health
February 24, 2017
Quintiles IMS Holdings, Inc. announced the pricing of the offering of €1.425 billion in gross proceeds of senior notes to be issued by its wholly owned subsidiary, Quintiles IMS Incorporated (the “Issuer”).
QuintilesIMS in FORTUNE’s 2017 list of ‘World’s Most Admired Companies’ financialexpress
February 21, 2017
The company has been recognised by FORTUNE as a most admired company for the third consecutive year
QuintilesIMS Reports Fourth-Quarter and Full-Year 2016 Results, Issues First-Quarter and Full-Year 2 IMS Health
February 15, 2017
Revenue of $1,953 million, up 74.2 percent constant currency, 73.1 percent reported; on a combined company basis up 4.2 percent constant currency, 3.5 percent at actual FX rates when adjusting for $55 million of deferred revenue for the fourth quarter
QuintilesIMS to Announce Fourth-Quarter 2016 Results and Issue 2017 Guidance on February 14, 2017 IMS Health
February 08, 2017
Quintiles IMS Holdings, Inc. will announce its fourth-quarter and full-year 2016 financial results and issue 2017 guidance before the market opens on Tuesday, February 14, 2017.